marijuana stocks

Form 8-K for CHUMA HOLDINGS, INC.


20-Apr-2015

Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers’ Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.Resignation of Jordan Shapiro

On April 17, 2015, Jordan Shapiro resigned as Chuma Holdings, Inc.’s (the “Company”) Chief Executive Officer (“CEO”) and member of the Board, effective immediately. The Company anticipates that it will continue to have a working relationship with Mr. Shapiro, but in a lesser capacity.

Appointment of Kevin Wright

On April 17, 2015, the Board appointed Kevin Wright, 41, as CEO of the Company.

Mr. Wright has served in a variety of senior executive and directorship positions, including a director position at a private marketing and advertising company. Mr. Wright has worked for businesses in Canada, the United States, and the United Kingdom where he was instrumental in formulating successful marketing strategies for clients such as Vonage, IBM, Akzo Nobel, Rogers, CIBC, and Molson’s. Over the course of his 20-year career, Mr. Wright has been an award-winning director for multi-national marketing and advertising companies.

On September 3, 2014, Mr. Wright began working for the Company as its President. The Company decided to offer Mr. Wright the role of CEO after having the opportunity to work with Mr. Wright, and evaluate his ability to read and predict market and customer needs.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Neptune Wellness Solutions Inc. (NEPT) Announces Launch of New Corporate and Investor Relations Websites

Neptune Announces Launch of New Corporate and Investor Relations Websites Neptune Wellness…

$VHUB Pays Third and Fourth Installment Of Interest Fees

Vapor Hub International Pays Third and Fourth Installment Of Interest, Fees Due…

$INSY Initiates Five Phase III Clinical Trials

Insys Therapeutics to Initiate Five Phase III Clinical Trials in 2015 PHOENIX,…

$CANV Announces Results of Quality and Safety Testing

Quality and Safety of CannaVest Corp.’s Products Proved by Independent Testing LAS…